Palatin Technologies
PTN
#10688
Rank
NZ$34.02 M
Marketcap
NZ$19.13
Share price
12.81%
Change (1 day)
N/A
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2026 (TTM): -NZ$10.61 Million

According to Palatin Technologies's latest financial reports the company's current earnings are NZ$12.88 Million. In 2025 the company made an earning of -NZ$16.33 Million, an increase over its 2024 earnings that were of -NZ$45.72 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$10.61 Million-35.01%
2025 -NZ$16.33 Million-64.29%
2024 -NZ$45.72 Million-16.9%
2023 -NZ$55.02 Million5.99%
2022 -NZ$51.91 Million-13.7%
2021 -NZ$60.15 Million33.25%
2020 -NZ$45.14 Million-172.11%
2019 NZ$62.59 M2352.33%
2018 NZ$2.55 M-94.13%
2017 NZ$43.49 M-154.92%
2016 -NZ$79.19 Million3.67%
2015 -NZ$76.39 Million878%
2014 -NZ$7.82 Million-72.64%
2013 -NZ$28.55 Million-33.11%
2012 -NZ$42.68 Million77.71%
2011 -NZ$24.02 Million
2003 -NZ$40.67 Million29.93%
2002 -NZ$31.3 Million36.18%
2001 -NZ$22.99 Million
1999 -NZ$19.08 Million6.04%
1998 -NZ$17.99 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$44.08 B-416,306.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$24.88 B-235,029.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
NZ$1.35 B-12,897.47%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-NZ$19.88 Million 87.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.32 B-3,151.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-NZ$0.2 Billion 1,784.89%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
NZ$0.19 B-1,958.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-NZ$50.04 Million 372.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-NZ$98.33 Million 828.28%๐Ÿ‡บ๐Ÿ‡ธ USA